Chicago-area doctors attest to innovation changing cardiology

In a new article from the Chicago Tribune, two Chicago-area physicians discuss the innovations that have changed and shaped the way heart patients are treated.

Charles Davidson, MD, who helped design the cardiology department at the new Northwestern Lake Forest Hospital, north of Chicago, said procedures are much less invasive than they used to be.

Ian Cohen, MD, the medical director of cardiology for Northwestern Lake Forest Hospital, has worked in the profession since 1993. He said many of the coronary devices that used to only be used in the operating room can now be used in cardiac catheterization labs. Because of technological advancements, patients at Northwestern are being treated much faster, he said.

To read more on how cardiology has changed, follow the link below:

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.